Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lo iatrosophion del codice Ott. gr. 312

Autor: Giannachi

L’articolo si occupa di due testi tramandati dal codice Ott. gr. 312 ai ff. 38v e 41. Lo iatrosophion presente nel f. 38v viene edito e contestualizzato nell’ambito delle testimonianze bizantine e postbizantine dello stesso genere.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4034::06a4c51594b62a3ab14a3d763f237c7d
https://hdl.handle.net/11587/424767

Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand Complexes.

Autor: Cansfield AD; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Ator MA; Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States., Banerjee J; Syngene International, Biocon Park, Bommasandra, Bangalore 560099, India., Bestwick M; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Bortolato A; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Brown GA; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Brown J; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Butkovic K; Fidelta d.o.o., Prilaz Baruna Filipovića 29, 10000 Zagreb, Croatia., Cansfield JE; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Christopher JA; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Congreve M; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Cseke G; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Deflorian F; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Dugan B; Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States., Hunjadi MP; Fidelta d.o.o., Prilaz Baruna Filipovića 29, 10000 Zagreb, Croatia., Hutinec A; Fidelta d.o.o., Prilaz Baruna Filipovića 29, 10000 Zagreb, Croatia., Inturi TK; Syngene International, Biocon Park, Bommasandra, Bangalore 560099, India., Landek G; Fidelta d.o.o., Prilaz Baruna Filipovića 29, 10000 Zagreb, Croatia., Mason J; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., O'Brien A; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Ott GR; Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States., Rupcic R; Fidelta d.o.o., Prilaz Baruna Filipovića 29, 10000 Zagreb, Croatia., Saxty G; Fidelta d.o.o., Prilaz Baruna Filipovića 29, 10000 Zagreb, Croatia., Southall SM; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K., Zadravec R; Fidelta d.o.o., Prilaz Baruna Filipovića 29, 10000 Zagreb, Croatia., Watson SP; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, U.K.

Publikováno v: ACS chemical neuroscience [ACS Chem Neurosci] 2022 Mar 16; Vol. 13 (6), pp. 751-765. Date of Electronic Publication: 2022 Mar 04.

Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.

Autor: Mirza AN; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA., Fry MA; Children's Hospital Oakland Research Institute, Oakland, California, USA., Urman NM; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA., Atwood SX; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA., Roffey J; CRUK Therapeutic Discovery Laboratories, London Bioscience Innovation Centre, London, United Kingdom., Ott GR; Teva Branded Pharmaceutical Products R&D, West Chester, Pennsylvania, USA., Chen B; Institute for Computational Health Sciences, UCSF, San Francisco, California, USA., Lee A; Children's Hospital Oakland Research Institute, Oakland, California, USA., Brown AS; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA., Aasi SZ; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA., Hollmig T; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA., Ator MA; Teva Branded Pharmaceutical Products R&D, West Chester, Pennsylvania, USA., Dorsey BD; Teva Branded Pharmaceutical Products R&D, West Chester, Pennsylvania, USA., Ruggeri BR; Teva Branded Pharmaceutical Products R&D, West Chester, Pennsylvania, USA., Zificsak CA; Teva Branded Pharmaceutical Products R&D, West Chester, Pennsylvania, USA., Sirota M; Institute for Computational Health Sciences, UCSF, San Francisco, California, USA., Tang JY; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA.; Children's Hospital Oakland Research Institute, Oakland, California, USA., Butte A; Institute for Computational Health Sciences, UCSF, San Francisco, California, USA., Epstein E; Children's Hospital Oakland Research Institute, Oakland, California, USA., Sarin KY; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA., Oro AE; Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA.

Publikováno v: JCI insight [JCI Insight] 2017 Nov 02; Vol. 2 (21). Date of Electronic Publication: 2017 Nov 02.